Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Editorial Picks · page 2
- UK & Europe
Portugal’s Regulator Defends Cannabis Crackdown as Export Permit Delays Fall
Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
- International Regulation
Australia’s Medical Cannabis Reforms to Target ‘Closed Loop’ Prescribing
Australia’s ongoing efforts to restrict its medical cannabis market, now the largest outside North America, are now taking aim at the special access scheme (SAS) framework on which the country’s hundreds of thousands of annual prescriptions are based.
- Industry Trends
What’s in Store for the Global Cannabis Industry in 2026? Mid-Year Update
This article was updated on September 02, 2026 In December 2025, we asked our in-house team of experts how they expected to see the industry evolve over the coming year.
- US & Canada
DEA Makes Its Final Case for Cannabis Rescheduling as Full Hearing Transcripts Published
As Chief Administrative Law Judge Derek Julius weighs his recommendation on moving cannabis to Schedule III, the DEA’s own closing brief attacks nearly every witness who opposed it — bar one scientist inside its own ranks.
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
- M&A Activity
Aurora Accuses Curaleaf of ‘Pressuring Shareholders’ as it Launches Official Takeover Bid
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- Business
Data is Becoming Cannabis’ Most Valuable Crop
For more than a decade now, the world’s largest retail conglomerates have been quietly building their consumer data empires.
- UK & Europe
New Report: Germany’s Cannabis Market Crosses €1.15bn as Reimbursement Era Ends
Germany’s medical cannabis market reached approximately €1.15bn in 2026, with private self-pay prescriptions now generating around 75% of total market value, according to a new whitepaper published today by Business of Cannabis and Prohibition Partners.
- Adult-Use
Thailand Presses Medical-Only Cannabis Bill Toward Cabinet as Enforcement Drive Widens
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
- Interviews
Cannabis Opportunity ‘Greater Today’ Than in 2019, Says the Lender Who Has Committed $550m
Just over a month ago, one of the most interesting and potentially consequential hearings in the history of US cannabis policy began.
- UK & Europe
Spain’s Tobacco Crackdown Could Quietly Wipe Out Its Cannabis Clubs
Last week, Spain’s government approved a draft tobacco law that never once mentions cannabis, yet could dismantle the everyday activity of the country’s thriving cannabis social clubs.
